FDA Inspection
Syntho Pharmaceuticals, Inc.Syntho Pharmaceuticals, Inc. – FDA Inspection, Feb 3, 2009
Record Details
This FDA Inspection record concerns Syntho Pharmaceuticals, Inc., with an inspection on February 3, 2009, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Syntho Pharmaceuticals, Inc.
- Inspection Date
- February 3, 2009
- Product Type
- Drugs
View Company Profile
ID · 263340af-9e5b-4a30-b8c5-03ad2a046304
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 560541
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Syntho Pharmaceuticals, Inc.
9| Date | Classification | Office | Project area |
|---|---|---|---|
| March 1, 2024 | Not classified | New York District Office | Drug Quality Assurance |
| September 3, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 9, 2017 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 26, 2016 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 23, 2013 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Syntho Pharmaceuticals, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.